|
1
|
Okuda K: Hepatocellular carcinoma. J
Hepatol. 32:225–237. 2000. View Article : Google Scholar
|
|
2
|
: A comparison of lipiodol
chemoembolization and conservative treatment for unresectable
hepatocellular carcinoma: Groupe d’ Etude et de Traitement du
Carcinome Hepatocellulaire. N Engl J Med. 332:1256–1261.
1995.PubMed/NCBI
|
|
3
|
Achenbach T, Seifert JK, Pitton MB, Schunk
K and Junginger T: Chemoembolization for primary liver cancer. Eur
J Surg Oncol. 28:37–41. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dumortier J, Chapuis F, Borson O, et al:
Unresectable hepatocellular carcinoma: survival and prognostic
factors after lipiodol chemoembolisation in 89 patients. Dig Liver
Dis. 38:125–133. 2006.PubMed/NCBI
|
|
5
|
Mondazzi L, Bottelli R, Brambilla G, et
al: Transarterial oily chemoembolization for the treatment of
hepatocellular carcinoma: a multivariate analysis of prognostic
factors. Hepatology. 19:1115–1123. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee HS, Kim KM, Yoon JH, et al:
Therapeutic efficacy of transcatheter arterial chemoembolization as
compared with hepatic resection in hepatocellular carcinoma
patients with compensated liver function in a hepatitis B
virus-endemic area: a prospective cohort study. J Clin Oncol.
10:4459–4465. 2002.
|
|
7
|
The Cancer of the Liver Italian Program. A
new prognostic system for hepatocellular carcinoma: a retrospective
study of 435 patients. Hepatology. 28:751–755. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sobin LH and Wittekind Ch; International
Union Against Cancer (UICC). Liver TNM Classification of Malignant
Tumours. 6th edition. John Wiley & Sons, Inc; New York:
2002
|
|
9
|
Mazzaferro V, Regalia E, Doci R, et al:
Liver transplantation for the treatment of small hepatocellular
carcinoma in patients with cirrhosis. N Engl J Med. 334:693–699.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brown DB, Gould JE, Gervais DA, et al:
Transcatheter therapy for hepatic malignancy: standardization of
terminology and reporting criteria. J Vasc Interv Radiol.
18:1469–1478. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Higashihara H and Okazaki M: Transcatheter
arterial chemoem bolization of hepatocellular carcinoma: a Japanese
experience. Hepatogastroenterology. 28:72–78. 2002.
|
|
12
|
Matsuo N, Uchida H, Nishimine K, et al:
Segmental transcatheter hepatic artery chemoembolization with
iodized oil for hepatocellular carcinoma: antitumor effect and
influence on normal tissue. J Vasc Interv Radiol. 4:543–549. 1993.
View Article : Google Scholar
|
|
13
|
Miyayama S, Matsui O, Yamashiro M, et al:
Ultraselective transcatheter arterial chemoembolization with a 2-f
tip microcatheter for small hepatocellular carcinomas: relationship
between local tumor recurrence and visualization of the portal vein
with iodized oil. J Vasc Interv Radiol. 18:365–376. 2007.
View Article : Google Scholar
|
|
14
|
Nakamura H, Liu T, Hori S, et al: Response
to transcatheter oily chemoembolization in hepatocellular carcinoma
3 cm or less: a study in 50 patients who underwent surgery.
Hepatogastroenterology. 3:6–9. 1993.PubMed/NCBI
|
|
15
|
Takayasu K, Muramatsu Y, Maeda T, et al:
Targeted transarterial oily chemoembolization for small foci of
hepatocellular carcinoma using a unified helical CT and angiography
system: analysis of factors affecting local recurrence and survival
rates. Am J Roentgenol. 176:681–688. 2001. View Article : Google Scholar
|
|
16
|
Ueno K, Miyazono N, Inoue H, Nishida H,
Kanetsuki I and Nakajo M: Transcatheter arterial chemoembolization
therapy using iodized oil for patients with unresectable
hepatocellular carcinoma: evaluation of three kinds of regimens and
analysis of prognostic factors. Cancer. 172:1574–1581. 2000.
View Article : Google Scholar
|
|
17
|
Ikai I, Arii S, Kojiro M, et al:
Reevaluation of prognostic factors for survival after liver
resection in patients with hepatocellular carcinoma in a Japanese
nationwide survey. Cancer. 101:796–802. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamamoto J, Kosuge T, Saiura A, et al:
Effectiveness of hepatic resection for early-stage hepatocellular
carcinoma in cirrhotic patients: subgroup analysis according to
Milan criteria. Jpn J Clin Oncol. 37:287–295. 2007. View Article : Google Scholar
|
|
19
|
Sung Y, Choi D, Lim H, et al: Long-term
results of percutaneous ethanol injection for the treatment of
hepatocellular carcinoma in Korea. Korean J Radiol. 7:187–192.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tateishi R, Shiina S, Teratani T, et al:
Percutaneous radiofrequency ablation for hepatocellular carcinoma.
An analysis of 1000 cases. Cancer. 103:1201–1209. 2005.PubMed/NCBI
|
|
21
|
Imvrios G, Papanikolaou V, Vrochides D, et
al: Liver transplantation outcomes in patients with cirrhosis and
hepatocellular carcinoma: experience of a single center in a viral
hepatitis endemic area. Transplant Proc. 39:1508–1510. 2007.
View Article : Google Scholar
|
|
22
|
Bruix J, Llovet J, Castells A, et al:
Transarterial embolization versus symptomatic treatment in patients
with advanced hepatocellular carcinoma: results of a randomized,
controlled trial in a single institution. Hepatology. 27:1578–1583.
1998. View Article : Google Scholar
|
|
23
|
Chen MS, Li JQ, Zhang YQ, et al: High-dose
iodized oil transcatheter arterial chemoembolization for patients
with large hepatocellular carcinoma. World J Gastroenterol.
8:74–78. 2001.PubMed/NCBI
|
|
24
|
Choi B, Kim H, Han J, et al: Therapeutic
effect of transcatheter oily chemoembolization therapy for
encapsulated nodular hepatocellular carcinoma: CT and pathologic
findings. Radiology. 182:709–713. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Eurvilaichit C: Outcome of transcatheter
oily chemoem bolization in patients with hepatocellular carcinoma.
Hepatogastroenterology. 51:20–24. 2004.PubMed/NCBI
|
|
26
|
Hashimoto N, Kawai S, Mikuriya S, et al:
Effects of transcatheter arterial chemoembolization with oral
chemotherapy on hepatic neoplasms. Cancer Chemother Pharmacol.
23:S21–S25. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kamada K, Nakanishi T, Kitamoto M, et al:
Long-term prognosis of patients undergoing transcatheter arterial
chemoembolization for unresectable hepatocellular carcinoma:
comparison of cisplatin lipiodol suspension and doxorubicin
hydrochloride emulsion. J Vasc Interv Radiol. 12:847–854. 2001.
View Article : Google Scholar
|
|
28
|
Maeda S, Shibata J, Fujiyama S, et al:
Long-term follow-up of hepatic arterial chemoembolization with
cisplatin suspended in iodized oil for hepatocellular carcinoma.
Hepatogastroenterology. 50:809–813. 2003.PubMed/NCBI
|
|
29
|
Okusaka T, Okada S, Ueno H, et al:
Transcatheter arterial embolization with zinostatin stimalamer for
hepatocellular carcinoma. Oncology. 62:228–233. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ono Y, Yoshimasu T, Ashikaga R, et al:
Long-term results of lipiodol-transcatheter arterial embolization
with cisplatin or doxorubicin for unresectable hepatocellular
carcinoma. Am J Clin Oncol. 23:564–568. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shimamura Y, Gunven P, Takenaka Y, et al:
Combined peripheral and central chemoembolization of liver tumors.
Experience with lipiodol-doxorubicin and gelatin sponge (L-TAE).
Cancer. 61:238–242. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stuart K, Stokes K, Jenkins R, Trey C and
Clouse M: Treatment of hepatocellular carcinoma using
doxorubicin/ethiodized oil/gelatin powder chemoembolization.
Cancer. 72:3202–3209. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Takayasu K, Arii S, Ikai I, et al:
Prospective cohort study of transarterial chemoembolization for
unresectable hepatocellular carcinoma in 8510 patients.
Gastroenterology. 131:461–469. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Takayasu K, Arii S, Matsuo N, et al:
Comparison of CT findings with resected specimens after
chemoembolization with iodized oil for hepatocellular carcinoma. Am
J Roentgenol. 175:699–704. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
O’Suilleabhain CB, Poon RT, Yong JL, Ooi
GC, Tso WK and Fan ST: Factors predictive of 5-year survival after
transarterial chemoembolization for inoperable hepatocellular
carcinoma. Br J Surg. 90:325–331. 2002.
|
|
36
|
Pelletier G, Ducreux M, Gay F, et al:
Treatment of unresectable hepatocellular carcinoma with lipiodol
chemoembolization: a multicenter randomized trial. Groupe CHC. J
Hepatol. 29:129–134. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pelletier G, Roche A, Ink O, et al: A
randomized trial of hepatic arterial chemoembolization in patients
with unresectable hepatocellular carcinoma. J Hepatol. 11:181–184.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Llovet J, Real M, Montana X, et al:
Arterial embolisation or chemoembolisation versus symptomatic
treatment in patients with unresectable hepatocellular carcinoma: a
randomised controlled trial. Lancet. 18:1734–1739. 2002. View Article : Google Scholar
|
|
39
|
Lo CM, Ngan H, Tso WK, et al: Randomized
controlled trial of transarterial lipiodol chemoembolization for
unresectable hepatocellular carcinoma. Hepatology. 35:1164–1171.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Takayasu K, Moriyama N, Muramatsu Y, et
al: Hepatic arterial embolization for hepatocellular carcinoma.
Comparison of CT scans and resected specimens. Radiology.
150:661–665. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kudo M, Chung H, Haji S, et al: Validation
of a new prognostic staging system for hepatocellular carcinoma:
the JIS score compared with the CLIP score. Hepatology.
40:1396–1405. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Georgiades C, Liapi E, Frangakis C, et al:
Prognostic accuracy of 12 liver staging systems in patients with
unresectable hepatocellular carcinoma treated with transarterial
chemoembolization. J Vasc Interv Radiol. 17:1619–1624. 2006.
View Article : Google Scholar
|
|
43
|
Kudo M, Chung H and Osaki Y: Prognostic
staging system forhepatocellular carcinoma (CLIP score): its value
and limitations, and a proposal for a new staging system, the Japan
Integrated Staging Score (JIS score). J Gastroenterol. 38:207–215.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Leung T, Tang A, Zee B, et al:
Construction of the Chinese University Prognostic Index for
hepatocellular carcinoma and comparison with the TNM staging
system, the Okuda staging system, and the Cancer of the Liver
Italian Program staging system: a study based on 926 patients.
Cancer. 94:1760–1769. 2002. View Article : Google Scholar
|
|
45
|
Ueno S, Tanabe G, Nuruki K, et al:
Prognosis of hepatocellular carcinoma associated with Child class B
and C cirrhosis in relation to treatment: a multivariate analysis
of 411 patients at a single center. J Hepatobiliary Pancreat Surg.
9:469–477. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ueno S, Tanabe G, Sako K, et al:
Discrimination value of the new western prognostic system (CLIP
score) for hepatocellular carcinoma in 662 Japanese patients.
Cancer of the Liver Italian Program. Hepatology. 34:529–534. 2001.
View Article : Google Scholar
|
|
47
|
Okuda K, Ohtsuki T, Obata H, et al:
Natural history of hepatocellular carcinoma and prognosis in
relation to treatment. Study of 850 patients. Cancer. 56:918–928.
1985. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pugh R, Murray-Lyon I, Dawson J, Pietroni
M and Williams R: Transection of the oesophagus for bleeding
oesophageal varices. Br J Surg. 60:646–669. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Majno PE, Sarasin FP, Mentha G and
Hadengue A: Primary liver resection and salvage transplantation or
primary liver transplantation or primary liver transplantation in
patients with single, small hepatocellular carcinoma and preserved
liver function: an outcome-oriented decision analysis. Hepatology.
31:899–906. 2000. View Article : Google Scholar
|
|
50
|
Belghiti J, Cortes A, Abdalla EK, et al:
Resection prior to liver transplantation for hepatocellular
carcinoma. Ann Surg. 238:885–892. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Roayaie S, Frischer JS, Emre SH, et al:
Long-term results with multimodal adjuvant therapy and liver
transplantation for the treatment of hepatocellular carcinomas
larger than 5 centimeters. Ann Surg. 235:533–539. 2002. View Article : Google Scholar : PubMed/NCBI
|
